Unlocking the power of AI-driven pathology in drug development: An Interview with Bristol Myers Squibb
2022-07-21T21:31:51-04:00Fierce Biotech July 21, 2022
Pharma / Biotech
A Conversation with Alan Lotvin, M.D. | Part 2
2022-07-21T20:58:53-04:00Managed Healthcare Executive July 21, 2022
California Initiative Provides $100 Million to Produce Its Own Insulin Biosimilars
2022-07-21T20:16:11-04:00AJMC July 21, 2022
Biologists train AI to generate medicines and vaccines
2022-07-21T19:50:57-04:00Medical Xpress July 21, 2022
Pilots Seek to Address Barriers to Diversity in Clinical Trials
2022-07-21T17:52:13-04:00Healthcare Innovation July 21, 2022
PhRMA funnels $10M into new grassroots clinical trial diversity initiative—and hopes Big Pharma will take note
2022-07-21T17:07:57-04:00Fierce Biotech July 21, 2022
Institute working to accelerate COVID-19 drug development
2022-07-21T15:35:18-04:00Medical Xpress July 21, 2022
There are too many blood cancer cell therapies in development, report says
2022-07-20T20:55:29-04:00Fierce Pharma July 20, 2022
Positive Outlook for Post-Pandemic Biotech
2022-07-21T20:50:17-04:00Pharmaceutical Executive July 20, 2022
VC Biotech Funding Collapses Amid Crowded Market
2022-07-20T20:49:54-04:00Healthcare Technology Report July 20, 2022
Marrying Precision Medicine to EHRs is a Priority at UH Cleveland
2022-07-20T20:48:51-04:00HealthLeaders Media July 20, 2022
A Conversation with Alan Lotvin, M.D. on the PBM Industry’s Reputation
2022-07-20T20:43:28-04:00Managed Healthcare Executive July 20, 2022
Cancer Research UK partnership aims to back 10 new startups
2022-07-20T20:36:35-04:00pharmaphorum July 20, 2022
PhRMA funds clinical trial initiative to achieve greater diversity
2022-07-20T20:06:20-04:00Healthcare Finance News July 20, 2022
The Impact of Pharmaceutical Wholesalers on U.S. Drug Spending
2022-07-20T20:01:38-04:00Commonwealth Fund July 20, 2022
Powerful Senate Democrat outlines ‘plenty’ more drug pricing reforms to follow Medicare negotiation
2022-07-20T19:43:25-04:00STAT July 20, 2022
Neuraxpharm Will Buy Sanofi CNS Portfolios
2022-07-20T17:34:14-04:00HealthLeaders Media July 20, 2022
How does the brain decide what memories are good and bad? A new mouse study offers clues
2022-07-20T17:22:03-04:00STAT July 20, 2022
Study details U.S. health spending by region2022-07-20T17:17:12-04:00
Incentives For Drug R&D: A Survey Of Biotech Venture Capitalists’ Perspectives
2022-07-20T17:07:44-04:00Health Affairs July 20, 2022
First nationwide, small-area analysis study details US health spending by region
2022-07-20T16:27:45-04:00Medical Xpress July 20, 2022
AI-Powered Microbial Mapping Paves the Way for Designer Gut Microbiomes
2022-07-19T20:56:05-04:00Bio-IT World July 19, 2022
Designing Digital Transformation for Life Sciences: Building Resiliency When Disruption is the New Normal
2022-07-19T20:50:04-04:00HIT Consultant July 19, 2022
Global pharmaceutical group urges equitable vaccine access before next pandemic
2022-07-19T20:02:10-04:00Becker's Healthcare July 19, 2022